Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracochlear vs round window application of triamcinolone acetonide for sudden sensorineural hearing loss
2020-005300-19Phase 4Active
- Sponsor
- Medical University of Vienna
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of triamcinolone acetonide in acute sensorineural hearing loss (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Mean hearing threshold shift. Started Nov 2020; status: active.
02
Drugs
triamcinolone acetonide
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on 2020-005300-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005300-19.